Anal and Stomal Procedures with CC DRG

DRG 348 encompasses inpatient admissions for anal and stomal procedures with a Complication or Comorbidity and captures cases with elevated clinical complexity. Proper classification under this Diagnosis-Related Group affects Medicare inpatient reimbursement by reflecting higher expected resource use when complications or comorbidities are present.

DRG 348 Overview

DRG 348 covers inpatient admissions for anal and stomal procedures when a Complication or Comorbidity is present. This Diagnosis-Related Group groups cases by procedure complexity and patient risk factors that affect resource use. It matters for Medicare payment because the presence of a Complication or Comorbidity increases the relative weight and influences reimbursement compared with cases without such comorbid conditions. Accurate coding of operative and comorbid diagnoses is essential for proper classification and payment under Medicare inpatient prospective payment systems.

DRG 348 Overview

Acute perioperative management studies: trials focused on optimizing intraoperative and immediate postoperative care for patients undergoing anal and stomal procedures with complicating conditions (eg, significant infection, bleeding, or cardiorespiratory comorbidities). These studies enroll hospitalized adults receiving index operations such as complex hemorrhoidectomy, fistulotomy with seton, or stoma creation/revision and compare protocols for anesthesia, fluid management, hemostasis techniques, and early infection prevention. Results inform clinicians on strategies to reduce in-hospital complications, length of stay, and resource use, which directly impact inpatient reimbursement and DRG-driven cost containment.
Comparative effectiveness trials of surgical and adjunctive approaches: randomized or pragmatic comparative studies evaluating different operative techniques (for example sphincter-sparing vs more extensive excisions), types of ostomy construction or closure methods, and adjunctive therapies such as topical agents or local wound care regimens. These trials typically enroll subgroups with specific pathology (eg, complex anorectal abscess/fistula, recurrent disease, or patients requiring permanent vs temporary stomas) to determine differences in wound healing, continence outcomes, readmission rates, and need for reoperation. Findings are relevant to providers choosing procedures that balance clinical benefit and complication risk, and to payers assessing comparative costs and long-term utilization tied to DRG payments.
Post-discharge outcomes and care-transition studies: observational cohorts and interventional trials assessing post-discharge recovery, ostomy self-care training, wound-care follow-up, and prevention of readmissions for patients discharged after anal or stomal procedures complicated by CC-level diagnoses. These studies focus on high-risk populations such as older adults, patients with diabetes or immunosuppression, and those living in rural or resource-limited settings, evaluating metrics like readmission frequency, outpatient utilization, patient-reported quality of life, and ostomy-related complications. Insights help hospitals and payers design discharge planning, home health, and outpatient support programs to reduce costly readmissions and improve value under DRG-based reimbursement.

Acute perioperative management studies: trials focused on optimizing intraoperative and immediate postoperative care for patients undergoing anal and stomal procedures with complicating conditions (eg, significant infection, bleeding, or cardiorespiratory comorbidities). These studies enroll hospitalized adults receiving index operations such as complex hemorrhoidectomy, fistulotomy with seton, or stoma creation/revision and compare protocols for anesthesia, fluid management, hemostasis techniques, and early infection prevention. Results inform clinicians on strategies to reduce in-hospital complications, length of stay, and resource use, which directly impact inpatient reimbursement and DRG-driven cost containment.
Comparative effectiveness trials of surgical and adjunctive approaches: randomized or pragmatic comparative studies evaluating different operative techniques (for example sphincter-sparing vs more extensive excisions), types of ostomy construction or closure methods, and adjunctive therapies such as topical agents or local wound care regimens. These trials typically enroll subgroups with specific pathology (eg, complex anorectal abscess/fistula, recurrent disease, or patients requiring permanent vs temporary stomas) to determine differences in wound healing, continence outcomes, readmission rates, and need for reoperation. Findings are relevant to providers choosing procedures that balance clinical benefit and complication risk, and to payers assessing comparative costs and long-term utilization tied to DRG payments.
Post-discharge outcomes and care-transition studies: observational cohorts and interventional trials assessing post-discharge recovery, ostomy self-care training, wound-care follow-up, and prevention of readmissions for patients discharged after anal or stomal procedures complicated by CC-level diagnoses. These studies focus on high-risk populations such as older adults, patients with diabetes or immunosuppression, and those living in rural or resource-limited settings, evaluating metrics like readmission frequency, outpatient utilization, patient-reported quality of life, and ostomy-related complications. Insights help hospitals and payers design discharge planning, home health, and outpatient support programs to reduce costly readmissions and improve value under DRG-based reimbursement.

OpenPayer

Anal and Stomal Procedures with CC: Inpatient Reimbursement Overview

Sign up for drg 348 policy alerts

DRG 348 Overview

OpenPayer

Anal and Stomal Procedures with CC: Inpatient Reimbursement Overview

Sign up for drg 348 policy alerts

DRG 348 Overview

Clinical Trials

Related Codes

References

Clinical Trials

Related Codes

References